Related Experiment Video
Updated: May 21, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
A case of paliperidone-palmitate-induced tardive dyskinesia
John Lally1, Fintan Byrne, Elizabeth Walsh
1National University of Ireland Galway, Galway, Ireland. john.lally@kcl.ac.uk
Objectives:
This is one of the first cases reported in the literature of paliperidone-palmitate-induced prolonged dyskinesia.
Method:
Case report.
Results:
We report the case of a 49-year-old woman with paranoid schizophrenia who developed orofacial dyskinesia some 4 months after the commencement of paliperidone long-acting injection.
Conclusion:
This case serves as a clinical reminder that dyskinesia can occur with all antipsychotic medications.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Huntington Disease l: Introduction
Antipsychotic Drugs: Typical and Atypical Agents
Alterations in Muscle Tone lll
Psychosis and Antipsychotic Drugs: Overview

